Building a global consensus approach to chordoma: a position paper from the medical and patient community
Top Cited Papers
- 1 February 2015
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 16 (2), e71-e83
- https://doi.org/10.1016/s1470-2045(14)71190-8
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapyAnnals of Oncology, 2012
- Carbon ion radiotherapy for sacral chordomaThe British Journal of Radiology, 2011
- Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patientsNeurosurgical Review, 2011
- Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas—106 cases review in one institutionNeurosurgical Review, 2010
- T (brachyury) gene duplication confers major susceptibility to familial chordomaNature Genetics, 2009
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor SarcomasJournal of Clinical Oncology, 2009
- Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine SarcomasInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Carbon Ion Radiotherapy for Skull Base ChordomaJournal of Neurological Surgery Part B: Skull Base, 2009
- Conventional external radiotherapy in the management of clivus chordomas with overt residual diseaseNeurological Sciences, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000